RecruitingNot ApplicableNCT07745244

Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System

Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System Across Varying Blood Glucose Ranges

Sponsor

SiBionics, Co, Ltd

Enrollment

36 participants

Start Date

Jun 1, 2026

Study Type

INTERVENTIONAL

Conditions

CGM Type1diabetes T1D

Summary

The study is to evaluate the accuracy and safety of a real-time CGM system among adult patients with type 1 diabetes with respect to reference venous plasma sample measurements.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called GS3 CGM for people with cgm, t1d, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.